New SCM Facility to Begin Production After MHRA Approval

By Dan Stanton

- Last updated on GMT

Related tags: Pharmacology, Varicose veins

SCM PHarma's new plant gets regulatory thumbs up
SCM PHarma's new plant gets regulatory thumbs up
SCM Pharma says its new contract manufacturing facility will cater for clients upscaling towards commercial production and the trend towards orphan drugs.

The Newburn facility near Newcastle, UK cost £6m ($10m) to construct and yesterday the company announced it had received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to begin commercial production.

Newburn will ensure the company has the capacity to deal with increasing demand coming from clients at SCM’s nearby clinical manufacturing facility - which deals "with novel new clinical trial projects that need developing and small scale sterile manufacturing"​ - looking to scale up towards commercial production, Managing Director at SCM Dianne Sharp told Outsourcing-Pharma.com.

Furthermore, she added the new facility will allow the firm to deal with licensed products in niche markets on the lower end of the volume scale.

“This has been our sweet spot for several commercial clients over the last few years and we have seen increasing demand in-line with the trend towards personalised medicines.”

Operations are set to begin at the back-end of summer with an oral syringe filling project for an undisclosed EU client with a dedicated suite put in place along with filling and packaging equipment.

According to Sharp, this reinforces the manufacturing progression that the company hopes to provide with the facility:

“We carried out the clinical supply of this product and are now the commercial supply partner with Newburn at the hub of the operation.”

Last month the company was named as commercial supplier for BTG’s​ candidate treatment for varicose veins, Varisolve, which – if approval is granted – could prove lucrative for both BTG and SCM.

The 26,000 sq ft site includes a range of packaging and labeling areas, temperature controlled warehousing, raw materials and engineering preparation, visual inspection and leak testing, and has led to a 45% increase in staff at SCM, jumping from 75 to 110.

Related news

Show more

Related products

show more

Automating clinical trials for success

Automating clinical trials for success

Formedix | 06-Oct-2021 | Technical / White Paper

This article gives gives a brief overview of why automation is absolutely essential for clinical trial success.

Empowering Clinical Trial Sponsors with Analytics

Empowering Clinical Trial Sponsors with Analytics

PerkinElmer | 14-Jul-2021 | Technical / White Paper

Is your Clinical Data Review creating problems or solving them? Take Control of Your Data. PerkinElmer Informatics Clinical Solutions, powered by Tibco...

Why Blister Packaging: Things to Consider

Why Blister Packaging: Things to Consider

Catalent Pharma Solutions | 03-Dec-2020 | Insight Guide

The decision to use blister packaging for either clinical trials or commercial drug manufacturing comes with a host of factors to consider. Pharmaceutical...

Related suppliers

Follow us

Products

View more

Webinars